InvestorsHub Logo
Followers 230
Posts 15196
Boards Moderated 0
Alias Born 03/30/2005

Re: Gohel Yoerselph post# 339234

Sunday, 01/10/2021 8:04:22 AM

Sunday, January 10, 2021 8:04:22 AM

Post# of 402819
Look up NLS. They are working with an israeli company on a pan-viral vaccine. if you read the various pr's on the new collaboration as well as GMU furthering it's research on Brilacidin, including pan-corona virus and in vivo testing, as well as other topics noted, it seems NLS would be a benefit. They collaborate with GMU, not IPIX (as per the PR). IPIX would get the benefit of this collaboration IMHO

the above is all IMHO (consider this my safe harbor statement)

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News